Scholars@Duke

CD8+ T cells: mechanistic target of rapamycin and eukaryotic initiation factor 2 in elite HIV-1 control.

Publication ,  Journal Article
Nyanhete, T; Tomaras, GD
Published in: AIDS
November 28, 2018
Published version (DOI) Link to item

Duke Scholars

Georgia Doris Tomaras
Author Georgia Doris Tomaras Surgery, Surgical Sciences
Altmetric Attention Stats
Dimensions Citation Stats

Published In

AIDS

DOI

10.1097/QAD.0000000000002008

EISSN

1473-5571

Publication Date

November 28, 2018

Volume

32

Issue

18

Start / End Page

2835 / 2838

Location

England

Related Subject Headings

  • Virology
  • Sirolimus
  • Metabolic Networks and Pathways
  • Humans
  • HIV-1
  • HIV Infections
  • Eukaryotic Initiation Factor-2
  • CD8-Positive T-Lymphocytes
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Nyanhete, T., & Tomaras, G. D. (2018). CD8+ T cells: mechanistic target of rapamycin and eukaryotic initiation factor 2 in elite HIV-1 control. AIDS, 32(18), 2835–2838. https://doi.org/10.1097/QAD.0000000000002008
Nyanhete, Tinashe, and Georgia D. Tomaras. “CD8+ T cells: mechanistic target of rapamycin and eukaryotic initiation factor 2 in elite HIV-1 control.” AIDS 32, no. 18 (November 28, 2018): 2835–38. https://doi.org/10.1097/QAD.0000000000002008.
Nyanhete, Tinashe, and Georgia D. Tomaras. “CD8+ T cells: mechanistic target of rapamycin and eukaryotic initiation factor 2 in elite HIV-1 control.” AIDS, vol. 32, no. 18, Nov. 2018, pp. 2835–38. Pubmed, doi:10.1097/QAD.0000000000002008.

Published In

AIDS

DOI

10.1097/QAD.0000000000002008

EISSN

1473-5571

Publication Date

November 28, 2018

Volume

32

Issue

18

Start / End Page

2835 / 2838

Location

England

Related Subject Headings

  • Virology
  • Sirolimus
  • Metabolic Networks and Pathways
  • Humans
  • HIV-1
  • HIV Infections
  • Eukaryotic Initiation Factor-2
  • CD8-Positive T-Lymphocytes
  • 42 Health sciences
  • 32 Biomedical and clinical sciences